| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide
|
Moyer, Richard R
|
|
1983
|
106 |
5P2 |
p. 1250-1253
4 p.
|
article
|
| 2 |
Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients
|
Chrysant, Steven G
|
|
1983
|
106 |
5P2 |
p. 1243-1250
8 p.
|
article
|
| 3 |
Cardiovascular disease and multifactorial risk: Challenge of the 1980s
|
Castelli, William P
|
|
1983
|
106 |
5P2 |
p. 1191-1200
10 p.
|
article
|
| 4 |
Clinical hemodynamic profile of trimazosin in hypertension
|
Pool, Peter E
|
|
1983
|
106 |
5P2 |
p. 1237-1242
6 p.
|
article
|
| 5 |
Discussion—Session I
|
Leren, Paul
|
|
1983
|
106 |
5P2 |
p. 1214-1215
2 p.
|
article
|
| 6 |
Discussion—Session III
|
Birkenhäger, W.H
|
|
1983
|
106 |
5P2 |
p. 1281-1283
3 p.
|
article
|
| 7 |
Double-blind comparison of trimazosin and propranolol in essential hypertension
|
Helgeland, Anders
|
|
1983
|
106 |
5P2 |
p. 1253-1258
6 p.
|
article
|
| 8 |
Effect of trimazosin on serum lipid profiles in hypertensive patients
|
Singleton, Walter
|
|
1983
|
106 |
5P2 |
p. 1265-1268
4 p.
|
article
|
| 9 |
Effects of trimazosin and prazosin on blood pressure and on pressor responses to phenylephrine in rats
|
Constantine, Jay W
|
|
1983
|
106 |
5P2 |
p. 1216-1221
6 p.
|
article
|
| 10 |
Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intolerance
|
Ames, Richard P
|
|
1983
|
106 |
5P2 |
p. 1207-1214
8 p.
|
article
|
| 11 |
Opening remarks: Hypertension and the risk factor concept
|
Leren, Paul
|
|
1983
|
106 |
5P2 |
p. 1190-1191
2 p.
|
article
|
| 12 |
Opening remarks: Mismatch of essential hypertension's pathophysiology and current antihypertensive drugs: A perspective for alpha-1-adrenergic blockade
|
Birkenhäger, W.H
|
|
1983
|
106 |
5P2 |
p. 1235-1236
2 p.
|
article
|
| 13 |
Pharmacokinetics and pharmacodynamics of trimazosin in man
|
Reid, John L
|
|
1983
|
106 |
5P2 |
p. 1222-1228
7 p.
|
article
|
| 14 |
Pharmacokinetics of a sustained-release trimazosin tablet formulation
|
Flouvat, B
|
|
1983
|
106 |
5P2 |
p. 1228-1234
7 p.
|
article
|
| 15 |
Profile of trimazosin: An effective and safe antihypertensive agent
|
Taylor, Colin R
|
|
1983
|
106 |
5P2 |
p. 1269-1281
13 p.
|
article
|
| 16 |
Summary
|
Birkenhäger, W.H
|
|
1983
|
106 |
5P2 |
p. 1283-1284
2 p.
|
article
|
| 17 |
The Oslo study: CHD risk factors, socioeconomic influences, and intervention
|
Leren, Paul
|
|
1983
|
106 |
5P2 |
p. 1200-1206
7 p.
|
article
|
| 18 |
Trimazosin for the treatment of hypertensive patients failing to respond to thiazides
|
Oberman, Albert
|
|
1983
|
106 |
5P2 |
p. 1258-1264
7 p.
|
article
|
| 19 |
Welcome
|
Saxton, Craig
|
|
1983
|
106 |
5P2 |
p. 1189-
1 p.
|
article
|
Journal description